Transcript Steve_Presentation - Foundation for Nuclear Studies

Overview of B&W Medical Isotope
Production System
Foundation for Nuclear Studies
September 27, 2011
Steve Schilthelm
Deputy Program Manager
.1
The Babcock & Wilcox Company
Government Operations
B&W Technical
Services Group, Inc.
Manages and operates
high-consequence
facilities, provides
technical services and
support to government
agencies and private
customers
B&W Nuclear
Operations Group, Inc.
Manufactures nuclear
components for U.S.
Department of Energy
Power Generation Systems
B&W Power
Generation Group, Inc.
B&W Nuclear
Energy , Inc.
Manufactures and
services coal, biomass,
CNG, concentrated solar
power plant equipment, &
Nox, Sox, mercury
scrubbers
Manufactures commercial
nuclear components and
provides services to
commercial nuclear
market
High-Consequence Operations & Services
Advanced Engineering and Manufacturing
.2
Covidien Reach Extends Globally and Locally
20,000+ U.S. employees,
41,000+ worldwide
Diverse healthcare products
used in all clinical settings
Products manufactured in
17 states
Nuclear Medicine:
One of two U.S. suppliers of
technetium 99m (Tc 99m)
Image used by permission of Covidien
Covidien Tc 99m-based
products sold in all 50 states
.3
B&W MIPS – 99Mo Production Using
Aqueous Homogeneous Reactor
 Market studies in Late 1990s
 Patented
in 1997 (Dr. Russell M. Ball)
 2007 MIPS project re-initiated
 2009 Agreement with Covidien
 2009 Cooperative Agreement with NNSA
 Non-proliferation
 Domestic
(LEU)
supply
AHR using LEU offers safety, safeguards, simplicity and waste advantages
.4
AHRs are not New Technology
CLEVELAND, OH
CLEVELAND, OH
SHEBA Reactor, LANL
Over 30 AHRs Built and Operated
.5
AHR - America’s First University Reactor
N.C. State’s – R1 (1953-73)
.6
Traditional Technology
235U
Target
Fabrication
Transport
Target Irradiation: Several days
Reactor: 10,000 -100,000 kilowatts
99mTc
User
Medical Facilities
Dissolved Target
Waste with 235U
Transport
99Mo
Processing
Facility
99mTc
Generator Facility
.7
B&W MIPS Technology
MIPS Facility
AHR Reactor
240 kilowatts- 5 days
99mTc
User
Medical Facilities
Initial Fuel
Solution Preparation
Reactor fuel/target
solution returned
for subsequent
irradiation
99mTc
99Mo
Generator Facility
Processing Cells
.8
Completing R&D Phase of Project
 National Laboratories

Argonne

Los Alamos
 Armed Forces Radiobiology
Research Institute, MD
 Purdue University
 B&W Labs, VA
 INVAP, Argentina
.9
MIPS Project Progress
 Conceptual design complete
 NRC licensing and waste policy decisions
complete
 Environmental analysis prepared
 Completing R&D activities
 Following legislation (HR 3276, S 99)
 Entering detailed design and licensing phase of
the project
.10
B&W MIPS Summary
Mo-99 production using LEU
AHR results in:
 Increased efficiency
 Reduced waste
 No proliferation concerns
 Safe operation
 Stable domestic supply
.11